Pulling SEC filings + quote and writing the call…

TALPHERA, INC.
Next earnings Aug 12, 2026 · consensus $-0.07 EPS
Last earnings +5.1% on 2026-05-13
Conservative balance sheet (liabilities/equity 0.74x); but unprofitable (net margin -51035.7%).
Revenue (FY2025) $28.0K · FY2025
TALPHERA, INC. shows $28.0K in FY2025 revenue, a -51035.7% net margin, and -83.9% ROE.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $2.82M | $0.00 | $651K | $0.00 | $28.0K |
| Gross profit | — | — | — | — | — |
| Operating income | -$36.0M | -$25.3M | -$16.9M | -$15.3M | -$13.5M |
| Net income | -$35.1M | $47.8M | -$18.4M | -$13.0M | -$14.3M |
| Diluted EPS | -$5.86 | $5.72 | -$1.29 | — | — |
| Net margin | -1245.5% | — | -2826.0% | — | -51035.7% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001427925, latest 10-Q filed 2026-05-13) · EODHD · as of 6/26/2026, 7:22:24 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-06-22 | WAN MARK A Director | Award | 5.10K | |
| 2026-06-22 | Todisco Joseph Director | Award | 5.10K | |
| 2026-06-22 | JAIN ABHINAV Director | Award | 5.10K | |
| 2026-06-22 | HOFFMAN STEPHEN J Director | Award | 5.10K | |
| 2026-06-22 | Broadfoot Jill Marie Director | Award | 5.10K | |
| 2026-06-22 | Bozilenko Marina Director | Award | 5.10K | |
| 2026-06-22 | ADAMS ADRIAN Director | Award | 5.10K | |
| 2026-05-20 | Aslam Shakil Chief Medical Officer | Tax | 4.52K @ $0.82 | $3.72K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1044 tracked peers · median